DEF 14AThe Ballot
Viking Therapeutics, Inc. files DEF 14A
Filed Apr 7, 2022 · 4y ago · Accession 0001564590-22-013875
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- Viking Therapeutics, Inc.
- Ticker
- VKTX
- CIK
- 1607678
- Form type
- DEF 14A
- Filing date
- Apr 7, 2022
- Report date
- May 24, 2022
- Document
- vktx-def14a_20220524.htm
- Size
- 948 KB